No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US Stock MarketDetailed Quotes
MPLN MultiPlan
- 0.435
- -0.010-2.31%
Close Jun 14 16:00 ET
- 0.447
- +0.012+2.69%
Post 18:15 ET
280.58MMarket Cap-448P/E (TTM)
0.448High0.419Low1.36MVolume0.428Open0.445Pre Close591.93KTurnover0.53%Turnover RatioLossP/E (Static)644.87MShares2.29052wk High0.24P/B111.66MFloat Cap0.37052wk Low--Dividend TTM256.62MShs Float12.930Historical High--Div YieldTTM6.56%Amplitude0.370Historical Low0.436Avg Price1Lot Size
Full Hours
- 5D
- 1D
- 1W
- 1M
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
MultiPlan Named to Fortune Best Workplaces in New York List for 2024
NEW YORK--(BUSINESS WIRE)--$MPLN #MPLN--MultiPlan Corporation (NYSE: MPLN) ("MultiPlan" or the "Company"), a leading value-added provider of data analytics and technology-enabled end-to-end cost manag
12 Health Care Stocks Moving In Wednesday's After-Market Session
GainersAnitra (AMEX:AZTR) shares increased by 6.5% to $0.18 during Wednesday's after-market session. The market value of their outstanding shares is at $5.1 million. Oragenics (AMEX:OGEN) shares incre
Express News | NYSE Order Imbalance 62816.0 Shares on Buy Side
Why Investors Shouldn't Be Surprised By MultiPlan Corporation's (NYSE:MPLN) 28% Share Price Plunge
To the annoyance of some shareholders, MultiPlan Corporation (NYSE:MPLN) shares are down a considerable 28% in the last month, which continues a horrid run for the company.
12 Health Care Stocks Moving In Tuesday's After-Market Session
GainersConcord Medical Services (NYSE:CCM) shares moved upwards by 131.0% to $4.85 during Tuesday's after-market session. The company's market cap stands at $210.6 million. Calidi Biotherapeutics (AME
Express News | NYSE Order Imbalance 555895.0 Shares on Buy Side
Comments
1
The company's poor revenue performance and bleak future revenue outlook are likely causing its low P/S ratio and weak share price. Investors are probably waiting for a performance improvement before considering it a good value. It's unlikely that the share price will rise significantly soon.
1
Investors are pessimistic about MultiPlan's future growth due to its low P/S ratio and falling revenue. The company's disappointing revenue forecast is a key factor in its low P/S, with investors doubting the potential for significant revenue improvement.
Investors seem to be trading MultiPlan at a lower P/S due to its inferior revenue outlook. Given the company's lackluster revenue performance and forecasts, it seems unlikely that its share price will see a significant rise in the near future.
Read more
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg
Rusty Shackleford 1 : Hey, let's make posts with a bunch of pointless stocks because I was kicked in the head by a horse